SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001990498-23-000004
Filing Date
2023-12-26
Accepted
2023-12-26 16:10:56
Documents
4
Period of Report
2023-12-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1703625045.html 3  
1 FORM 3 wk-form3_1703625045.xml 3 6123
2 EX-24 exhibit24-powerofattorne.htm EX-24 5193
3 exhibit24-powerofattorne001.jpg GRAPHIC 248800
4 exhibit24-powerofattorne002.jpg GRAPHIC 91720
  Complete submission text file 0001990498-23-000004.txt   482006
Mailing Address 103 CARNEGIE CENTER DRIVE, SUITE 309 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER DRIVE, SUITE 309 PRINCETON NJ 08540 (609) 486-2308
LianBio (Issuer) CIK: 0001831283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O LIANBIO 103 CARNEGIE CENTER DRIVE, SUITE 309 PRINCETON NJ 08540
Business Address
Gu Ehong (Reporting) CIK: 0001990498 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40947 | Film No.: 231513440